for those wuth her+ brain mets--new clinical trial opened
high dose trastuzumab with pertuzumab and atezolizumab ( anti-PDL1 immunotherapy) in patients with HER2+ CNS disease--pi Nancy Lin,
Dana Farber. |
All times are GMT -7. The time now is 07:07 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021